Dr. Zhang has been working on Real-World research in pharmaceutical and medical device industry for over 15 years. He is dedicated to promoting global universal standards for electronic health databases in the Asia-Pacific region, practicing emerging theories and methods in epidemiological research, and advancing Real-World Evidence guided by the value of clinical practice. He leads a team in establishing database framework and scientific research collaboration in multiple countries in the Asia-Pacific region, providing scientific consultation and training on Real-World research, and conducting cross-national Real-World studies in multiple therapeutic areas to support new indication expansion, pre- and post-market regulatory requirements, evaluation for drug safety and rational drug use in scientific management throughout the entire product lifecycle. At present, he has more than 20 scientific papers and over 50 conference abstracts published in international academic journals and conferences, which have been widely recognized by academic and regulatory institutions. Prior to Johnson & Johnson, he worked in the Epidemiology Department at Novartis, where he was responsible for providing epidemiological support to various functions in the Greater China region, as well as assisting the R&D department on scientific research collaboration with external KOLs.